To be clear: Theres currently no published research exploring the relationship between semaglutide (Ozempic) and the effectiveness of birth control
Recently, Altimmune reported interim data for its weekly injectable GLP-1/glucagon dual agonist (pemvidutide) in a Phase 2 trial--disappointing levels of discontinuations sent the stock tumbling 55%
What are the practical implications for treating diabetes in light of recent evidence
Head-to-head clinical data from the SURMOUNT-5 trial shows tirzepatide (Mounjaro) achieves greater weight loss
In alignment with other GLP-1RAs, severe or blood glucose-confirmed symptomatic hypoglycemia was infrequent in the PIONEER programs, although it seemed to occur more frequently in trials combining oral semaglutide with sulfonylureas (SU) or insulin (PIONEER 3, 5, 7, and 8) [8, 10, 12, 13]
Studies show that people using Semaglutide lose an average of 10-15% of their body weight over a year